BioTek Instruments Expands into Switzerland
News Jan 27, 2010
BioTek Switzerland was created from a previous partnership with Witec AG in Littau, Switzerland and will be managed by Margrit Limacher, Witec’s founder. Ms. Limacher will also continue management of the existing Witec AG with their focus on life science products at the same location.
“This new company is a logical result of Witec’s successful BioTek division business operations, and is expected to offer the same level of professional service and support for future growth,” noted Margrit Limacher. “Our customers will continue to have unrestricted and competent service and support when evaluating BioTek’s microplate instrumentation solutions.”
Briar Alpert, BioTek President and CEO added, “This enhanced business relationship will allow BioTek Switzerland to be well-connected to BioTek USA’s information systems with complete access to the company’s global scientific and application resources. Ultimately, this means enhanced customer satisfaction for our Swiss customers.”
BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.
CRISPR Reveals New Targets for Promising Cancer DrugsNews
Novel screening method identifies new drug targets that could potentially enhance the effectiveness of PD-1 checkpoint inhibitors, a promising new class of cancer immunotherapy.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Big-Data Analysis Points Toward New Drug Discovery MethodNews
A research team has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018